Navigation Links
Centene Corporation to Present at Upcoming Healthcare Conferences
Date:11/6/2009

ST. LOUIS, Nov. 6 /PRNewswire-FirstCall/ -- Centene Corporation (NYSE: CNC) today announced that it will present at two upcoming healthcare conferences over the next few weeks.

Next week, at the Credit Suisse 18th Annual Health Care Conference, to be held November 11-13, 2009, at the Arizona Biltmore Resort and Spa in Phoenix, Centene will present Wednesday, November 11th at 4:30 p.m. Mountain Time. Investors and other interested parties may access Centene's presentation at: http://w.on24.com/r.htm?e=174781&s=1&k=E91138148481B8AE93D26A4DB82EFF7D.

The following week, Centene will present on Thursday, November 19th at 3:05 p.m. Eastern Time at Citi's 6th Annual Small/Mid Cap Conference, to be held November 19-20, at the Citigroup Global Markets Offices in New York City. Anyone interested in accessing a live, audio webcast of Centene's presentation may do so via the following website: http://www.veracast.com/webcasts/citigroup/smid09/28111122.cfm.

A webcast replay can be accessed shortly after each presentation via the Company's website at www.centene.com under the Investors section.

About Centene Corporation

Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including the Children's Health Insurance Program (CHIP), as well as Aged, Blind, or Disabled (ABD), Foster Care, Long-Term Care and Medicare (Special Needs Plans). The Company operates local health plans and offers a wide range of health insurance solutions to individuals and the rising number
'/>"/>

SOURCE Centene Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Centene Foundation for Quality Healthcare Awards Grant to Community Health Center
2. Centene Foundation for Quality Healthcare Awards Grant to Center for Black Womens Wellness
3. Centene Corporation Unveils Winners of the 2008 Physician Summit Award
4. Centene Foundation for Quality Healthcare Awards Grant to Texas Parent to Parent
5. ETEX Corporation Announces Distribution Agreement with Alphatec Spine
6. Select Medical Holdings Corporation Announces Results for Third Quarter Ended September 30, 2009
7. Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation
8. Quantros Acquires MediQual(TM) From CareFusion Corporation
9. Dialysis Corporation of America Reports Third Quarter 2009 Results
10. Service Corporation International Announces Third Quarter 2009 Financial Results
11. NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... N.Y. -- Hockey fans likely would assume that body-checking ... causes the most injuries in youth ice hockey. But ... study, the largest and most comprehensive analysis to date ... overall injuries were caused by accidentally hitting the boards ... by a puck. , Only 34 percent of the ...
(Date:7/29/2010)... more than a thousand genes known as large intergenic ... to understanding the function and organization of the genome. ... with the finding that dozens of these lincRNAs are ... cancer), suggesting that this class of genes plays a ... researchers identify one lincRNA in particular (lincRNA-p21), and demonstrate ...
(Date:7/29/2010)... a family history of male breast cancer perceive themselves to ... patients with a family history of female breast cancer; however ... likely to know about or seek genetic testing than those ... a study led by researchers at the University of Louisville,s ... rare and accounts for only about one percent of all ...
(Date:7/29/2010)... game, developed at the University of Stavanger (UiS), is set ... , If you mention the words "drug calculationss" to a ... in return. Not only is it a difficult subject, the ... mistake in the examination leads to fail, which again bars ... medication can be fatal., At UiS the students have three ...
(Date:7/29/2010)... in Spanish . , Mushrooms are among ... in keeping the immune system healthy. Now, Agricultural Research ... study showing that white button mushrooms enhanced the activity ... In the United States, white button mushrooms represent 90 ... was conducted at the Jean Mayer USDA Human Nutrition ...
Breaking Medicine News(10 mins):Health News:Most youth hockey injuries caused by accidents, not checking, UB study shows 2Health News:'Linc-ing' a noncoding RNA to a central cellular pathway 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 3Health News:Playing with pills 2
... (Nasdaq: WHRT ) World Heart ... Investigational Device Exemption ("IDE") application to the US Food ... pivotal Bridge-to-Transplant ("BTT") study of the Levacor(TM) Ventricular Assist ... information, including design and in vitro and ...
... affected women,s ability to plan and prepare for expensive long-term ... new survey released today by America,s Health Insurance Plans (AHIP). ... found that 60 percent of women say the economy has ... "Women have been particularly hard hit by the ...
... hear it everywhere: "What is your carbon footprint?" But ... can you reduce yours? It isn,t all that complicated, ... to bring it down.Listen to this report from Siemens (NYSE: ... access video, audio, text, graphics and photos for free and ...
... prolongs lives of key vision cells in mice , , ... mice have identified a protein that appears to prolong ... diseased eyes. , The discovery could one day lead ... predisposed to develop retinal disease, the scientists said. , ...
... Yet another reason to use a treadmill desk to ... ... January 8, 2009 -- Yet another alarm bell has been set ... and the corresponding relation to disease. The National Cancer Institute completed ...
... N.C., Jan. 8 Many electronic health record,systems are ... when a child goes to his,or her primary care ... physician,s,office -- the fields in the child,s electronic health ... fields are not appropriate,for newborns; growth tracking and immunization ...
Other Medicine News:Health News:WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 3Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3Health News:Alliance for Pediatric Quality Supports New ANSI-Approved Standard for Child Health Passed by HL7 2
(Date:7/29/2010)... Asahi Kasei Medical Co., Ltd. is pleased ... of BioOptimal™ MF-SL, its new range of microfilters ... culture clarification applications, BioOptimal™ MF-SL filters enable biopharmaceutical manufacturers ... harvest step. , ... Developed using Asahi Kasei,s ...
(Date:7/29/2010)... Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host a ... of Q2 financial results on Monday, August 16, 2010 . , ... Conference Call Information ... To access the live ... States and Canada or +1 212 231 2901 internationally. ...
(Date:7/29/2010)... PITTSBURGH , July 29 With diabetes affecting the ... Ohio , Giant Eagle®, Inc. has announced that it will begin ... at no cost to medical prescription holders. , ... (Logo:   http://photos.prnewswire.com/prnh/20100729/NE42933LOGO ) , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20100729/NE42933LOGO ) , ...
Breaking Medicine Technology:Launch of BioOptimal™ MF-SL Microfilters for Bioprocessing 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 2Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 3Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 4Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 5X Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement 16816 1X Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement 16816 2Watson Launches Generic Exelon AE 9552 1Watson Launches Generic Exelon AE 9552 2Watson Launches Generic Exelon AE 9552 3Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 1Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 2Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 3Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 4
... Science Corporation,announced today that enrollment has completed in ... designed to enhance memory. The,IMPACT ("Improvement in Memory ... more than five hundred adults aged 65+,seeking to ... Principal Investigators for the IMPACT trial are ...
... of Phase II Study in Previous Nonresponders ... Schering-Plough,Corporation (NYSE: SGP ) today ... for boceprevir, its investigational oral hepatitis C,protease ... II study in,treatment-naive (previously untreated) hepatitis C ...
Other Medicine Technology:Study Demonstrates Mindful Approach to Aging 2Study Demonstrates Mindful Approach to Aging 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 2Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 4Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 5Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 6Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 7Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 8Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 9
... The Apollo Knee System has been ... through range of motion of any fixed ... area and low contact stress under loading ... contributes to long-term effectiveness. The universal symmetrical ...
The Performance Knee System is a wide and easy to use system that offers enough options to cover any indication for primary and revision knee surgery, and all this with extensive intraoperative flexi...
... component is intended for patients who ... ligament stability, yet require augmentation and/or ... stock. The NexGen CRA femoral component ... surface. This device is for cemented ...
The Duracon system provides superb articular conformity throughout the range of motion, reducing contact stresses generally associated with wear....
Medicine Products: